|
| Olfactory ensheathing cells travel their natural nasal pathway to deliver therapeutics to brain tumors |
|
https://doi.org/10.18632/oncotarget.27043
Litia A. Carvalho, Bakhos A. Tannous
|
| 4351-4353 |
|
| PET-guided treatment in advanced-stage Hodgkin lymphoma: yes but which one? |
|
https://doi.org/10.18632/oncotarget.27045
Cédric Rossi, Olivier Casasnovas
|
| 4354-4355 |
|
| Differential gene expression and AKT targeting in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.27026
Feng-Mao Lin, Susan E. Yost, Wei Wen, Paul H. Frankel, Daniel Schmolze, Pei-Guo Chu, Yate-Ching Yuan, Zheng Liu, John Yim, Zhen Chen, Yuan Yuan
|
| 4356-4368 |
|
| Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS) |
|
https://doi.org/10.18632/oncotarget.27028
Goro Kasuya, Kazuki Terashima, Kei Shibuya, Shingo Toyama, Daniel K. Ebner, Hiroshi Tsuji, Tomoaki Okimoto, Tatsuya Ohno, Yoshiyuki Shioyama, Takashi Nakano, Tadashi Kamada
|
| 4369-4379 |
|
| Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells |
|
https://doi.org/10.18632/oncotarget.27029
Elvin Peter Chizenga, Rahul Chandran, Heidi Abrahamse
|
| 4380-4396 |
|
| Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study |
|
https://doi.org/10.18632/oncotarget.27030
Dorte Schou Nørøxe, Olga Østrup, Christina Westmose Yde, Lise Barlebo Ahlborn, Finn Cilius Nielsen, Signe Regner Michaelsen, Vibeke Andrée Larsen, Jane Skjøth-Rasmussen, Jannick Brennum, Petra Hamerlik, Hans Skovgaard Poulsen, Ulrik Lassen
|
| 4397-4406 |
|
| Dicer prevents genome instability in response to replication stress |
|
https://doi.org/10.18632/oncotarget.27034
Michalis Fragkos, Viviana Barra, Tom Egger, Benoit Bordignon, Delphine Lemacon, Valeria Naim, Arnaud Coquelle
|
| 4407-4423 |
|
| Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo |
|
https://doi.org/10.18632/oncotarget.27040
Elgilda Musi, Gary K. Schwartz, Jae Hyuk Yoo, Shannon J. Odelberg, Dean Y. Li, Michael Y. Bonner, Ponniah Selvakumar, Shikha Rao, Linda C. Gilbert, Justin Elsey, Jack L. Arbiser
|
| 4424-4436 |
|
| Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer |
|
https://doi.org/10.18632/oncotarget.27055
Laris Achlaug, Rive Sarfstein, Karthik Nagaraj, Lena Lapkina-Gendler, Ilan Bruchim, Manisha Dixit, Zvi Laron, Shoshana Yakar, Haim Werner
|
| 4437-4448 |
|
| Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme |
|
https://doi.org/10.18632/oncotarget.27056
Yvonne Becker, Sarah Förster, Gerrit H. Gielen, Ian Loke, Morten Thaysen-Andersen, Christine Laurini, Kristin Wehrand, Torsten Pietsch, Simone Diestel
|
| 4449-4465 |
|
| Improvement of the rituximab–induced cell death by potentiation of the store-operated calcium entry in mantle cell lymphoma cell lines |
|
https://doi.org/10.18632/oncotarget.27063
Isabelle Doignon, Olivier Fayol, Olivier Dellis
|
| 4466-4478 |
|
| CD90low MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer |
|
https://doi.org/10.18632/oncotarget.27065
Yang Zeng, Binghao Li, Tao Li, Wei Liu, Chongzhao Ran, Richard T. Penson, Mark C. Poznansky, Yanan Du, Huabiao Chen
|
| 4479-4491 |
|
| Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease |
|
https://doi.org/10.18632/oncotarget.27037
Luigi Maiuri, Valeria Raia, Mauro Piacentini, Antonella Tosco, Valeria Rachela Villella, Guido Kroemer
|
| 4492-4500 |
|
| Correction: Downregulation of lncRNA MEG3 and miR-770-5p inhibit cell migration and proliferation in Hirschsprung’s disease |
|
https://doi.org/10.18632/oncotarget.27049
Hongxing Li, Bo Li, Dongmei Zhu, Hua Xie, Chunxia Du, Yankai Xia, Weibing Tang
|
| 4501-4502 |
|
| Correction: RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation |
|
https://doi.org/10.18632/oncotarget.27066
Susanne V. Schmidt, Stefanie Seibert, Barbara Walch-Rückheim, Benjamin Vicinus, Eva-Maria Kamionka, Jennifer Pahne-Zeppenfeld, Erich-Franz Solomayer, Yoo-Jin Kim, Rainer M. Bohle, Sigrun Smola
|
| 4503-4504 |
|
| Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency |
|
https://doi.org/10.18632/oncotarget.27073
Jayaraju Dheekollu, Kimberly Malecka, Andreas Wiedmer, Henri-Jacques Delecluse, Alan K.S. Chiang, Dario C. Altieri, Troy E. Messick, Paul M. Lieberman
|
| 4505-4506 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
